Wave Life Sciences LtdWVE
Price$3.70Intrinsic value$6.0062% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $6.00median of 2 methodsbased on filings through 30 Jun 2026
Market Price $3.70Price as of 30 Sep 2026
Margin of Safety +62.1%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: -1.7%/yr (balance of the path).-0.4% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 6-0.8%Yr 70.2%Yr 81.1%Yr 92.1%Yr 103.0%
-1.7% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 5.4%
Volatility vs market (adjusted beta)-0.54

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetWave Life Sciences LtdWVEHealth Care
Valuation
P/E—
P/S13.4×
P/B2.0×
EV / Revenue8.0×
EV / EBITDA-10.1×
Profitability
Gross margin100.0%
Operating margin-81.8%
Net margin-309.7%
FCF margin-295.5%
Returns
ROE-44.6%
ROA-36.3%
ROIC—
Growth
Revenue growth (YoY)-39.6%
5-yr fwd EPS growth-0.4%
Financial strength
Debt / Equity0.03×
Current ratio9.99×
Altman Z-Score1.2
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.